Matching articles for "Immune globulin"
Advice for Travelers
The Medical Letter on Drugs and Therapeutics • November 1, 2009; (Issue 87)
Patients planning to travel to other countries often ask physicians for information about appropriate vaccines and prevention of diarrhea and malaria. Guidelines are also available from the Infectious Diseases...
Patients planning to travel to other countries often ask physicians for information about appropriate vaccines and prevention of diarrhea and malaria. Guidelines are also available from the Infectious Diseases Society of America (IDSA).
VariZIG for Prophylaxis After Exposure to Varicella
The Medical Letter on Drugs and Therapeutics • August 14, 2006; (Issue 1241)
The US manufacturer of varicella zoster immune globulin (VZIG; Massachusetts Public Health Biologic Laboratories, Boston, MA) recently discontinued its production. A Canadian formulation, VariZIG (Varicella...
The US manufacturer of varicella zoster immune globulin (VZIG; Massachusetts Public Health Biologic Laboratories, Boston, MA) recently discontinued its production. A Canadian formulation, VariZIG (Varicella Zoster Immune Globulin [Human] - Cangene Corporation, Winnipeg) is now available in the US under an investigational new drug application expanded access protocol.
Advice For Travelers
The Medical Letter on Drugs and Therapeutics • March 1, 1996; (Issue 969)
Patients planning to travel to other countries often ask physicians for advice about immunizations
and prevention of diarrhea and malaria. More detailed advice for travelers is
available from the CDC at...
Patients planning to travel to other countries often ask physicians for advice about immunizations
and prevention of diarrhea and malaria. More detailed advice for travelers is
available from the CDC at 877-FYI-TRIP (877-394-8747) or www.cdc.gov/travel.
Immune Globulin IV for Prevention of RH Isoimmunization and for Treatment of ITP
The Medical Letter on Drugs and Therapeutics • January 19, 1996; (Issue 966)
immune globulin (human) has been available for many years in an intramuscular (IM) formulation for prevention of Rh isoimmunization in pregnant Rh-negative women (Medical Letter, 16:3, 1974). Recently, the US...
immune globulin (human) has been available for many years in an intramuscular (IM) formulation for prevention of Rh isoimmunization in pregnant Rh-negative women (Medical Letter, 16:3, 1974). Recently, the US Food and Drug Administration (FDA) approved the first intravenous (IV) immune globulin preparation (WinRho SD - Univax), not only for preventing Rh isoimmunization, but also for treatment of immune thrombocytopenic purpura (ITP) in Rh-positive patients.